Csaba P Kovesdy, MD

The Fred Hatch Professor of Medicine in Nephrology

MEMPHIS TN 381632116
Tel: (901) 448-2985

Research Description

Dr. Kovesdy’s research interests are centered on epidemiology and outcomes, cardiovascular risk factors, metabolic abnormalities, race-ethnicity, and bone and mineral disorders in pre-dialysis chronic kidney disease. He is Principal Investigator on several studies and federal grants in these areas. He has published his research in over 300 peer-reviewed articles, as well as numerous abstracts and book chapters. 

Research Keywords

Chronic kidney disease



Progression of CKD


Blood pressure

Cardiovascular risk factors



Bone-mineral metabolism

Research Interest/Specialty

Outcomes in patients with non-dialysis dependent CKD


Clincial trials


  1. Obi, Y, Nguyen, DV, Streja, E, Rivara, MB, Rhee, CM, Lau, WL, Chen, Y, Kovesdy, CP, Mehrotra, R, Kalantar-Zadeh, K. Development and Validation of a Novel Laboratory-Specific Correction Equation for Total Serum Calcium and its Association with Mortality among Hemodialysis Patients. J Bone Miner Res, 2016.
  2. Kim, S, Molnar, MZ, Fonarow, GC, Streja, E, Wang, J, Gillen, DL, Mehrotra, R, Brunelli, SM, Kovesdy, CP, Kalantar-Zadeh, K, Rhee, CM. Mean platelet volume and mortality risk in a national incident hemodialysis cohort. Int J Cardiol, 220, 862-70, 2016.
  3. Gosmanova, EO, Kovesdy, CP. Blood Pressure Targets in CKD: Lessons Learned from SPRINT and Previous Observational Studies. Curr Cardiol Rep, 18 (9), 88, 2016.
  4. Molnar, MZ, Ravel, V, Streja, E, Kovesdy, CP, Rivara, MB, Mehrotra, R, Kalantar-Zadeh, K. Survival of Elderly Adults Undergoing Incident Home Hemodialysis and Kidney Transplantation. J Am Geriatr Soc, 2016.
  5. Molnar, MZ, Nagy, K, Remport, A, Gaipov, A, Fülöp, T, Czira, ME, Kovesdy, CP, Mucsi, I, Mathe, Z. Association Between Serum Leptin Level and Mortality in Kidney Transplant Recipients. J Ren Nutr, 2016.
  6. Rossignol, P, Legrand, M, Kosiborod, M, Hollenberg, SM, Peacock, WF, Emmett, M, Epstein, M, Kovesdy, CP, Yilmaz, MB, Stough, WG, Gayat, E, Pitt, B, Zannad, F, Mebazaa, A. Emergency management of severe hyperkalemia: Guideline for best practice and opportunities for the future. Pharmacol Res, 113 (Pt A), 585-591, 2016.
  7. Kovesdy, CP. Updates in hyperkalemia: Outcomes and therapeutic strategies. Rev Endocr Metab Disord, 2016.
  8. Gosmanova, EO, Mikkelsen, MK, Molnar, MZ, Lu, JL, Yessayan, LT, Kalantar-Zadeh, K, Kovesdy, CP. Association of Systolic Blood Pressure Variability With Mortality, Coronary Heart Disease, Stroke, and Renal Disease. J Am Coll Cardiol, 68 (13), 1375-86, 2016.
  9. Lu, JL, Molnar, MZ, Ma, JZ, George, LK, Sumida, K, Kalantar-Zadeh, K, Kovesdy, CP. Racial differences in association of serum calcium with mortality and incident cardio- and cerebrovascular events. J Clin Endocrinol Metab, jc20161802, 2016.
  10. Rhee, CM, You, AS, Koontz Parsons, T, Tortorici, AR, Bross, R, St-Jules, DE, Jing, J, Lee, ML, Benner, D, Kovesdy, CP, Mehrotra, R, Kopple, JD, Kalantar-Zadeh, K. Effect of high-protein meals during hemodialysis combined with lanthanum carbonate in hypoalbuminemic dialysis patients: findings from the FrEDI randomized controlled trial. Nephrol Dial Transplant, 2016.
  11. Rhee, CM, Ravel, VA, Streja, E, Mehrotra, R, Kim, S, Wang, J, Nguyen, DV, Kovesdy, CP, Brent, GA, Kalantar-Zadeh, K. Thyroid Functional Disease and Mortality in a National Peritoneal Dialysis Cohort. J Clin Endocrinol Metab, jc20161691, 2016.
  12. Mathew, A, Obi, Y, Rhee, CM, Chen, JL, Shah, G, Lau, WL, Kovesdy, CP, Mehrotra, R, Kalantar-Zadeh, K. Treatment frequency and mortality among incident hemodialysis patients in the United States comparing incremental with standard and more frequent dialysis. Kidney Int, 2016.
  13. Wang, J, Streja, E, Soohoo, M, Chen, JL, Rhee, CM, Kim, T, Molnar, MZ, Kovesdy, CP, Mehrotra, R, Kalantar-Zadeh, K. Concurrence of Serum Creatinine and Albumin With Lower Risk for Death in Twice-Weekly Hemodialysis Patients. J Ren Nutr, 2016.
  14. Kalantar-Zadeh, K, Kovesdy, CP. Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? No, We Should Never Again Compromise Safety. Diabetes Care, 39 (7), 1281-6, 2016.
  15. Kovesdy, CP. The Reply. Am J Med, 129 (7), e93, 2016.
  16. Molnar, MZ, Nguyen, DV, Chen, Y, Ravel, V, Streja, E, Krishnan, M, Kovesdy, CP, Mehrotra, R, Kalantar-Zadeh, K. Predictive Score for Posttransplantation Outcomes. Transplantation, 2016.
  17. Bhandari, SK, Shi, J, Molnar, MZ, Rasgon, SA, Derose, SF, Kovesdy, CP, Calhoun, DA, Kalantar-Zadeh, K, Jacobsen, SJ, Sim, JJ. Comparisons of sleep apnoea rate and outcomes among patients with resistant and non-resistant hypertension. Respirology, 2016.
  18. Norris, KC, Mensah, GA, Boulware, LE, Lu, JL, Ma, JZ, Streja, E, Molnar, MZ, Kalantar-Zadeh, K, Kovesdy, CP. Age, Race and Cardiovascular Outcomes in African American Veterans. Ethn Dis, 26 (3), 305-14, 2016.
  19. Ravel, VA, Streja, E, Mehrotra, R, Sim, JJ, Harley, K, Ayus, JC, Amin, AN, Brunelli, SM, Kovesdy, CP, Kalantar-Zadeh, K, Rhee, CM. Serum sodium and mortality in a national peritoneal dialysis cohort. Nephrol Dial Transplant, 2016.
  20. Kalantar-Zadeh, K, Moore, LW, Tortorici, AR, Chou, JA, St-Jules, DE, Aoun, A, Rojas-Bautista, V, Tschida, AK, Rhee, CM, Shah, AA, Crowley, S, Vassalotti, JA, Kovesdy, CP. North American experience with Low protein diet for Non-dialysis-dependent chronic kidney disease. BMC Nephrol, 17 (1), 90, 2016.
  21. Lu JL, Kalantar-Zadeh K, Ma JZ, Quarles LD, Kovesdy CP. Association of Body Mass Index with Outcomes in Patients with CKD. J Am Soc Nephrol, 2014.
  22. Molnar MZ, Kalantar-Zadeh K, Lott EH, Lu JL, Malakauskas SM, Ma JZ, Quarles DL, Kovesdy CP. Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease. J Am Coll Cardiol, 7 (63), 650-658, 2014.
  23. Kovesdy CP, Lu JL, Molnar MZ, Ma JZ, Canada RB, Streja E, Kalantar-Zadeh K, Bleyer AJ. Observational Modeling of Strict vs. Conventional Blood Pressure Control in Patients with Chronic Kidney Disease. JAMA Int Med, 2014.
  24. Kovesdy, CP, Quarles, LD, Lott, EH, Lu, JL, Ma, JZ, Molnar, MZ, Kalantar-Zadeh, K. Survival advantage in black versus white men with CKD: effect of estimated GFR and case mix. Am J Kidney Dis, 62 (2), 228-35, 2013.
  25. Kovesdy, CP, Lott, EH, Lu, JL, Malakauskas, SM, Ma, JZ, Molnar, MZ, Kalantar-Zadeh, K. Outcomes associated with microalbuminuria: effect modification by chronic kidney disease. J Am Coll Cardiol, 61 (15), 1626-33, 2013.
  26. Kovesdy CP, Bleyer AJ, Molnar MZ, Ma JZ, Sim JJ, Cushman WC, Quarles LD, Kalantar-Zadeh K. Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study. Ann Intern Med, 4 (159), 233-42, 2013.
  27. Kovesdy, CP, Lott, EH, Lu, JL, Malakauskas, SM, Ma, JZ, Molnar, MZ, Kalantar-Zadeh, K. Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation, 125 (5), 677-84, 2012.
  28. Kovesdy, CP, Lu, JL, Malakauskas, SM, Andress, DL, Kalantar-Zadeh, K, Ahmadzadeh, S. Paricalcitol versus ergocalciferol for secondary hyperparathyroidism in CKD stages 3 and 4: a randomized controlled trial. Am J Kidney Dis, 59 (1), 58-66, 2012.
  29. Kovesdy CP, Czira ME, Rudas A, Ujszaszi A, Rosivall L, Novak M, Kalantar-Zadeh K, Molnar MZ, Mucsi I. Body Mass Index, Waist Circumference and Mortality in Kidney Transplant Recipients. Am J Transplant, 12 (10), 2644-51, 2010.
  30. Kovesdy CP, George SM, Anderson JA, Kalantar-Zadeh K. Outcome-predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease. Am J Clin Nutr, 2 (90), 407-14, 2009.